AgomAb Therapeutics NV (AGMB)
7.96
-0.44
(-5.24%)
USD |
NASDAQ |
Oct 28, 16:00
7.99
+0.03
(+0.38%)
Pre-Market: 09:27
AgomAb Therapeutics Shareholders Equity (Quarterly) : 153.74M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 153.74M |
| Date | Value |
|---|---|
| December 31, 2024 | 194.76M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| Invion Ltd. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Total Liabilities (Quarterly) | 26.78M |